HAAHHeritage Assessment and History (Epping, Australia)
HAAHHapten Antibody Anti-Hapten Method (histology)
References in periodicals archive ?
HAAH is an excellent target for monoclonal antibody cancer therapeutics, and we have developed several high affinity antibodies against HAAH with good promise as cancer therapeutics," commented K.
This fact, coupled with the exclusivity of the surface expression of HAAH to cancer cells, suggests the potential clinical utility of PAN-622 for the specific delivery of cytotoxic agents to cancer cells.
In vitro, Panacea has shown that monoclonal antibodies against HAAH inhibit cell growth in a dose-dependent fashion, inhibit cell motility more than 6-fold and reduce invasion from 26% to 0.
HAAH was discovered by researchers at Brown University (Providence, RI) and the Rhode Island Hospital.